EXPERIMENTAL THERAPIES IN THE TREATMENT OF CUTANEOUS T-CELL LYMPHOMA

被引：15

作者：

FOSS, FM ^{[1
]}

KUZEL, TM ^{[1
]}

机构：

[1] NORTHWESTERN UNIV,SCH MED,CHICAGO,IL

来源：

HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA | 1995年 / 9卷 / 05期

关键词：

D O I：

10.1016/S0889-8588(18)30063-7

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Although meaningful clinical responses have been demonstrated in cutaneous T-cell lymphoma using a number of therapeutic modalities, survival benefits have not been demonstrated for the majority of patients. Several novel therapies, including retinoids, purine analogs, biologic response modifiers, monoclonal antibodies, and fusion toxins have demonstrated activity and clinical promise in early studies.

引用

页码：1127 / &

共 48 条

[31]

LEMAISTRE CF, 1991, BLOOD, V78, P1173

[32]

LEMAISTRE CF, 1992, BLOOD, V79, P2547

[33]

LEMAISTRE CF, 1993, BLOOD, V82, pA137

[34]

MOLIN L, 1984, RETINOIDS NEW TRENDS, P341

[35]

NAGATANI T, 1988, ACTA DERM-VENEREOL, V68, P504

[36]

OBRIEN S, 1994, BLOOD, V84, P733

[37]

PRZYBILLA B, 1983, ACTA DERM-VENEREOL, V63, P524

[38] RADIOIMMUNODETECTION AND RADIOIMMUNOTHERAPY OF CUTANEOUS T-CELL LYMPHOMAS USING AN I-131-LABELED MONOCLONAL-ANTIBODY - AN ILLINOIS CANCER COUNCIL STUDY [J].

ROSEN, ST ;

ZIMMER, AM ;

GOLDMANLEIKIN, R ;

GORDON, LI ;

KAZIKIEWICZ, JM ;

KAPLAN, EH ;

VARIAKOJIS, D ;

MARDER, RJ ;

DYKEWICZ, MS ;

PIERGIES, A ;

SILVERSTEIN, EA ;

ROENIGK, HH ;

SPIES, SM .

JOURNAL OF CLINICAL ONCOLOGY, 1987, 5 (04) :562-573

[39] SUCCESSFUL INTERLEUKIN-2 THERAPY OF ADVANCED CUTANEOUS T-CELL LYMPHOMA [J].

RYBOJAD, M ;

MAROLLEAU, JP ;

FLAGEUL, B ;

BACCARD, M ;

BRANDELY, M ;

MOREL, P ;

GISSELBRECHT, C .

BRITISH JOURNAL OF DERMATOLOGY, 1992, 127 (01) :63-64

[40]

SAVEN A, 1992, BLOOD, V80, P587

← 1 2 3 4 5 →